123 related articles for article (PubMed ID: 23944359)
1. Regulation of MET receptor signaling by SOCS1 and its implications for hepatocellular carcinoma.
Gui Y; Yeganeh M; Cepero-Donates Y; Ramanathan S; Saucier C; Ilangumaran S
Curr Pharm Des; 2014; 20(17):2922-33. PubMed ID: 23944359
[TBL] [Abstract][Full Text] [Related]
2. Regulation of MET receptor tyrosine kinase signaling by suppressor of cytokine signaling 1 in hepatocellular carcinoma.
Gui Y; Yeganeh M; Donates YC; Tobelaim WS; Chababi W; Mayhue M; Yoshimura A; Ramanathan S; Saucier C; Ilangumaran S
Oncogene; 2015 Nov; 34(46):5718-28. PubMed ID: 25728680
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic downregulation of the suppressor of cytokine signaling 1 (Socs1) gene is associated with the STAT3 activation and development of hepatocellular carcinoma induced by methyl-deficiency in rats.
Bagnyukova TV; Tryndyak VP; Muskhelishvili L; Ross SA; Beland FA; Pogribny IP
Cell Cycle; 2008 Oct; 7(20):3202-10. PubMed ID: 18843197
[TBL] [Abstract][Full Text] [Related]
4. SOCS1 controls liver regeneration by regulating HGF signaling in hepatocytes.
Gui Y; Yeganeh M; Ramanathan S; Leblanc C; Pomerleau V; Ferbeyre G; Saucier C; Ilangumaran S
J Hepatol; 2011 Dec; 55(6):1300-8. PubMed ID: 21703184
[TBL] [Abstract][Full Text] [Related]
5. Suppressor of cytokine signaling 1-dependent regulation of the expression and oncogenic functions of p21(CIP1/WAF1) in the liver.
Yeganeh M; Gui Y; Kandhi R; Bobbala D; Tobelaim WS; Saucier C; Yoshimura A; Ferbeyre G; Ramanathan S; Ilangumaran S
Oncogene; 2016 Aug; 35(32):4200-11. PubMed ID: 26725321
[TBL] [Abstract][Full Text] [Related]
6. Role of SOCS1 in tumor progression and therapeutic application.
Zhang J; Li H; Yu JP; Wang SE; Ren XB
Int J Cancer; 2012 May; 130(9):1971-80. PubMed ID: 22025331
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of MET-mediated migration and invasion in hepatocellular carcinoma cells by SOCS1.
Gui Y; Khan MGM; Bobbala D; Dubois C; Ramanathan S; Saucier C; Ilangumaran S
World J Gastroenterol; 2017 Sep; 23(36):6639-6649. PubMed ID: 29085209
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte growth control by SOCS1 and SOCS3.
Khan MGM; Ghosh A; Variya B; Santharam MA; Kandhi R; Ramanathan S; Ilangumaran S
Cytokine; 2019 Sep; 121():154733. PubMed ID: 31154249
[TBL] [Abstract][Full Text] [Related]
9. SOCS1 inhibits migration and invasion of prostate cancer cells, attenuates tumor growth and modulates the tumor stroma.
Villalobos-Hernandez A; Bobbala D; Kandhi R; Khan MG; Mayhue M; Dubois CM; Ferbeyre G; Saucier C; Ramanathan S; Ilangumaran S
Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):36-47. PubMed ID: 27779203
[TBL] [Abstract][Full Text] [Related]
10. SILAC proteomics implicates SOCS1 in modulating cellular macromolecular complexes and the ubiquitin conjugating enzyme UBE2D involved in MET receptor tyrosine kinase downregulation.
Santharam MA; Shukla A; Ihsan AU; Cloutier M; Levesque D; Ramanathan S; Boisvert FM; Ilangumaran S
Biochimie; 2021 Mar; 182():185-196. PubMed ID: 33493533
[TBL] [Abstract][Full Text] [Related]
11. Regulation of cytokine receptor signaling by SOCS1.
Ilangumaran S; Rottapel R
Immunol Rev; 2003 Apr; 192():196-211. PubMed ID: 12670405
[TBL] [Abstract][Full Text] [Related]
12. Hypermethylation of suppressor of cytokine signaling 1 in hepatocellular carcinoma patients.
Saelee P; Chuensumran U; Wongkham S; Chariyalertsak S; Tiwawech D; Petmitr S
Asian Pac J Cancer Prev; 2012; 13(7):3489-93. PubMed ID: 22994783
[TBL] [Abstract][Full Text] [Related]
13. Potent antitumor activity of oncolytic adenovirus-mediated SOCS1 for hepatocellular carcinoma.
Liu L; Li W; Wei X; Cui Q; Lou W; Wang G; Hu X; Qian C
Gene Ther; 2013 Jan; 20(1):84-92. PubMed ID: 22318090
[TBL] [Abstract][Full Text] [Related]
14. ANT2 suppression by shRNA may be able to exert anticancer effects in HCC further by restoring SOCS1 expression.
Jang JY; Jeon YK; Lee CE; Kim CW
Int J Oncol; 2013 Feb; 42(2):574-82. PubMed ID: 23242177
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene.
Jiang S; Zhang HW; Lu MH; He XH; Li Y; Gu H; Liu MF; Wang ED
Cancer Res; 2010 Apr; 70(8):3119-27. PubMed ID: 20354188
[TBL] [Abstract][Full Text] [Related]
16. Suppressors of cytokine signaling as tumor repressors. Silencing of SOCS3 facilitates tumor formation and growth in lung and liver.
Baltayiannis G; Baltayiannis N; Tsianos EV
J BUON; 2008; 13(2):263-5. PubMed ID: 18555475
[TBL] [Abstract][Full Text] [Related]
17. Tumour-promoting role of SOCS1 in colorectal cancer cells.
Tobelaim WS; Beaurivage C; Champagne A; Pomerleau V; Simoneau A; Chababi W; Yeganeh M; Thibault P; Klinck R; Carrier JC; Ferbeyre G; Ilangumaran S; Saucier C
Sci Rep; 2015 Sep; 5():14301. PubMed ID: 26391193
[TBL] [Abstract][Full Text] [Related]
18. Expression of SOCS1 and the downstream targets of its putative tumor suppressor functions in prostate cancer.
Chevrier M; Bobbala D; Villalobos-Hernandez A; Khan MG; Ramanathan S; Saucier C; Ferbeyre G; Geha S; Ilangumaran S
BMC Cancer; 2017 Feb; 17(1):157. PubMed ID: 28235401
[TBL] [Abstract][Full Text] [Related]
19. Suppressor of cytokine signaling 1 (SOCS1) limits NFkappaB signaling by decreasing p65 stability within the cell nucleus.
Strebovsky J; Walker P; Lang R; Dalpke AH
FASEB J; 2011 Mar; 25(3):863-74. PubMed ID: 21084693
[TBL] [Abstract][Full Text] [Related]
20. SOCS proteins: negative regulators of cytokine signaling.
Krebs DL; Hilton DJ
Stem Cells; 2001; 19(5):378-87. PubMed ID: 11553846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]